Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

Stem Cell Culture

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...

Source And Potency Of Stem Cells

Source And Potency Of Stem Cells

Stem cells are undifferentiated cells with extensive self-renewal properties that help them maintain their population during the fetal and adult stages of life. They can specialize in all cell types of the human body. However, their differential potential may vary and can be classified into five types. Stem cells can be (1) Totipotent, (2) Pluripotent, (3) Multipotent, (4) Oligopotent, and (5) Unipotent. Each stem cell has a specific origin; the fertilized egg or zygote is a totipotent cell and...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Multipotency of Hematopoietic Stem Cells

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Prioritizing Discovery and Advancements in Arrhythmia Therapies: NIH/NHLBI Workshop.

JACC. Clinical electrophysiology·2026

Same author

Beta-Adrenergic Stimulation and <i>MYH7</i> G256E Mutant Gene Dosage Drive Hypertrophic Cardiomyopathy Phenotype Penetrance.

bioRxiv : the preprint server for biology·2026

Same author

Tilmanocept Labels Granulomas in Cardiac Sarcoidosis.

Journal of cardiac failure·2026

Same author

Modeling early human heart development using an iPSC-based 3D bioprinted model of embryonic heart tube.

Nature communications·2026

Same author

Determining the individualized probability of myocardial recovery: The multicenter RecoverHeart calculator.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026

Same author

A Hypoxia-reoxygenation Injury Model in Self-assembling Human Cardioids.

Journal of visualized experiments : JoVE·2026

Search research articles

Related Experiment Video

Updated: Jul 7, 2026

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

Multipotent stem cells in cardiac regenerative therapy.

Ravi Karra¹, Sean M Wu

¹Brigham and Women's Hospital, Department of Medicine, 75 Francis Street, Boston, MA 02115, USA. rkarra@partners.org

Regenerative Medicine

|March 1, 2008

Summary

This summary is machine-generated.

Cardiovascular stem cell therapy shows limited heart function improvement. Understanding cell differentiation is key for future cardiac regeneration using embryonic stem cells and nuclear reprogramming.

More Related Videos

Induction of Endothelial Differentiation in Cardiac Progenitor Cells Under Low Serum Conditions

Induction of Endothelial Differentiation in Cardiac Progenitor Cells Under Low Serum Conditions

Published on: January 7, 2019

Derivation of Cardiac Progenitor Cells from Embryonic Stem Cells

Derivation of Cardiac Progenitor Cells from Embryonic Stem Cells

Published on: January 12, 2015

Related Experiment Videos

Last Updated: Jul 7, 2026

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

Induction of Endothelial Differentiation in Cardiac Progenitor Cells Under Low Serum Conditions

Induction of Endothelial Differentiation in Cardiac Progenitor Cells Under Low Serum Conditions

Published on: January 7, 2019

Derivation of Cardiac Progenitor Cells from Embryonic Stem Cells

Derivation of Cardiac Progenitor Cells from Embryonic Stem Cells

Published on: January 12, 2015

Area of Science:

Cardiovascular research
Regenerative medicine
Stem cell biology

Background:

Autologous stem cell therapy is being explored for heart disease treatment.
Current clinical trials using intracoronary infusion or myocardial injection show limited efficacy.
Lack of cardiomyogenesis and minimal heart function improvement highlight the need for better strategies.

Purpose of the Study:

To address the need for understanding cell-lineage commitment and cardiac differentiation principles.
To explore novel approaches for cardiac regeneration.
To evaluate the potential of embryologically-derived stem/progenitor cells for heart repair.

Main Methods:

Review of recent clinical trial data on stem cell therapy for heart disease.
Investigation into the differentiation potential of embryological stem/progenitor cells.
Consideration of nuclear reprogramming technologies.

Main Results:

Current stem cell infusion/injection methods yield limited functional improvement and no cardiomyogenesis.
Embryonic stem cells possess intrinsic competence for cardiac lineage differentiation.
Nuclear reprogramming offers potential for generating autologous cardiomyogenic cells.

Conclusions:

Understanding stem cell differentiation is crucial for effective cardiac regeneration.
Embryonic stem cells and nuclear reprogramming present promising avenues for future therapies.
Overcoming challenges like tumor risk is essential for clinical translation of embryonic stem cell transplantation.